Primary care referral to multidisciplinary high risk foot services – too few, too late by unknown
RESEARCH Open Access
Primary care referral to multidisciplinary
high risk foot services – too few, too late
D Plusch1, S Penkala1,4*, HG Dickson2,4 and M Malone1,3,4
Abstract
Background: To determine if patients with no contact with a multi-disciplinary team High Risk Foot Service (MDT-HRFS)
had an increased rate of hospital admission for diabetes foot infection compared to patients with contact. Secondary
aims were to report on clinical outcomes.
Methods: A retrospective study was conducted at a major tertiary referral hospital in metropolitan Sydney over
12 months. An ICD-10 search of the electronic medical record system and paper medical charts identified patients with
diabetes mellitus (type 1 or type 2) and a primary admission for diabetes foot infection (DFI). Patients were categorised as
having contact or no contact with an MDT-HRFS.
Results: One hundred ninety-six hospital admissions (156 patients) were identified with DFI over a 12-month period.
Patients with no contact with a MDT-HRFS represented three quarters of admissions (no contact = 116, 74.7 % vs.
contact = 40, 25.6 %, p = 0.0001) and presented with more severe infection (no contact = 39 vs. contact = 12). The odds
of lower extremity amputation increased five-fold when both no contact and severe infection occurred in combination
(no contact with severe infection and amputation = 34, 82.9 % vs. contact with severe infection and amputation = 7,
17.1 %, OR 4.9, 95 % CI 1.1–21.4, p = 0.037). Using estimates of both the contact and no contact population of people
with diabetes and high-risk feet and assuming the risk of amputation was the same, than the number of expected
amputations in the no contact group should have been 55, however the observed number was 77, 22 more than
expected (p = 0.0001).
Conclusions: Patients with no contact with a MDT-HRFS represented the majority of admissions for DFIs to a tertiary
referral hospital. This group on population estimates appears to be at high risk of amputation of the lower extremity
and therefore early referral of this high-risk group might lower this risk.
Background
Foot infections are one of the most common causes of
hospitalisation in people with diabetes [1, 2] with up to
85 % of cases proceeding to a diabetes related lower ex-
tremity amputation [3]. Most frequently DFIs are pre-
ceded by ulceration, where a break in the protective
barrier of the skin leaves a portal of entry for invading
pathogenic organisms. The deficit in the immune-
mediated response in people with diabetes may increase
the risk and severity of foot infections but the exact
underlying process responsible for this deficit, remains
poorly characterized [4]. Early recognition and appropriate
management of diabetes related foot pathology preceding
DFI’s therefore is essential.
Primary care practitioners while providing the majority
of medical care for people with diabetes, also play an im-
portant role in routine screening, identifying the risk of
diabetes related foot pathology and referral needs [5].
High risk foot stratification includes two or more risk
factors (peripheral neuropathy, peripheral vascular dis-
ease, deformity) and/or a history of ulceration, and/or
amputation [6]. Clinical guidelines recommend primary
referral of people with a high risk foot to a MDT-HRFS
with specialist care from medical, surgical, nursing, po-
diatry and allied health professionals [5, 7, 8].
Emergency referral to a MDT-HRFS within 24 h is
recommended when there is a new ulcer, swelling or
foot discolouration [8]. Grading severe infection on the
Infectious Disease Society of America (ISDA) guidelines,
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predicted hospitalisation and amputation rates 89 and
70 % respectively [6]. High-risk foot services have dem-
onstrated reductions in hospital admissions [9], amputa-
tions [10–16] and length of stay (LOS) [9, 12, 13, 16–18]
for patients known to the service. However, despite clin-
ical success rates and guidelines, many people with dia-
betes do not receive routine screening for diabetes related
foot pathology to enable appropriate early referrals [5].
While the main focus within the literature surrounds
MDT-HRFS and the reduction of DRLEA rates, there
has been no comparison of hospital admissions for DFIs
between people with contact and no contact to a MDT-
HRFS. The primary aim of this study was to determine if
patients with no contact to a MDT-HRFS were associ-
ated with increased numbers of hospital admission for
diabetes foot infection. Secondary aims were to report
on clinical outcomes in patients hospitalised for DFI,
with a focus on any surgical procedures required, LOS,
infection classification and cost.
Methods
A retrospective study was conducted at a major tertiary
referral hospital in metropolitan Sydney from 1st January
2012 to 1st January 2013. Ethical approval was obtained
from South Western Sydney Local Health District Re-
search and Ethics Committee. Patient information in-
cluding age, gender, medical history, clinical, laboratory,
operative report data and hospital metrics were collected
Patients were eligible if they had either type 1 or type 2
diabetes with a primary admission for DFI. Patients were
identified using the ICD-10 coding system.
District-linked electronic medical records and paper
medical charts were cross-referenced and used to identify
patients with ‘contact’ and ‘no contact’ to the MDT-HRFS.
Patients with contact were defined as any registered pa-
tient attending an outpatient appointment with the MDT-
HRFS in the preceding 12 months prior to admission. A
MDT-HRFS was defined according to Agency for Clinical
Innovation, Endocrine Network standards for high-risk
foot services in New South Wales, Australia. There are
four MDT-HRFS in the administrative district, each lo-
cated in a public hospital outpatient area.
People with diabetes and peripheral neuropathy con-
stitute a group at high risk for lower limb amputation as
a consequence of ulceration and infection. While neur-
opathy has been identified as an etiology in the majority
of DFI foot ulcerations [2, 19], peripheral vascular dis-
ease is present in over half [2] of those requiring hospi-
talisation and is a predictor of poor healing [2]. The size
of this group in our Health District is not known, but es-
timates can be generated. The population of the Health
District is 820,000. Approximately 8 % will have diabetes
[19], and of these about 60-70 % will have peripheral neur-
opathy and or peripheral arterial disease. The severity of
the neuropathy and or peripheral arterial disease is likely
to be normally distributed, and 20 % could be categorized
as being in the high risk group [20]. This gives a target
population at high risk of diabetic foot disease of approxi-
mately 8500 people. There are approximately 2500 ‘known’
patients on the patient register of the High Risk Foot Clinic
at our hospital location. ‘Unknown’ patients to the High
Risk Foot Clinic with high risk foot pathology are esti-
mated to be around 6000, derived from subtracting the
‘known’ patients from the target at risk population of 8500.
Outcomes of interest were: any foot surgery or vascular
procedure associated with the index admission, the length
of hospital stay, severity of infection (using current Infec-
tious Disease Society of America guidelines for diabetes
foot infection [2], inflammatory markers, culture results,
and estimated hospital costs. Past medical history in-
cluding comorbid variables in addition to clinical and
laboratory data were confirmed using current diagnos-
tic guidelines and obtained from both electronic med-
ical records and paper charts. In particular, PAD was
confirmed via documented clinical assessment and or
in combination with available vascular studies. Diabetes
peripheral neuropathy were confirmed through available
clinical indicators including a modified neuropathic dis-
ability score >6 [21] absent 10 g monofilament in >3
places on the foot [22] and or available diagnostic electro-
physiological studies.
Identified patients for the study were split into two co-
horts, contact and no contact to a MDT-HRFS.
Costs for each inpatient separation were calculated util-
izing AR-DRG (Independent Hospital Pricing Authority).
All values are represented in AUS $. For each patient, the
admission, discharge date, principal diagnosis, principal
procedure and co-morbidities were extracted and cross
checked between electronic records and paper charts.
The cost of each individual patient episode of admis-
sion was calculated. Multiple procedures during a single
admission were not calculated, and the cost was attrib-
uted to the highest surgical procedure cost. Thus if a
patient required revascularization and amputation, the
cost for amputation would be calculated as it is the
higher costing procedure. The cost of multiple admis-
sions within the 12-month period was also calculated for
individual patients.
Statistical analysis
Statistical analysis was undertaken using IBM Statistical
Packages for the Social Sciences (SPSS) Version 21.0 for
Windows (SPSS Inc, Chicago, IL, USA). Unpaired t tests
and chi square with risk ratio were employed in testing dif-
ferences between cohorts. Mann-Whitney U test was used
for nonparametric data. A histogram for hospital metric
data was performed to look for outliers and normality. For
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all comparisons and modelling, the level of significance
was set at p <0.05.
Results
A total of 196 hospital admissions (156 patients) were
identified from the ICD-10 search over the 12 month
study period. Of the 156 patients, the majority had
no contact with a MDT-HRFS (no contact = 116,
74.7 % vs. contact = 40 patients, 25.6 %, p = 0.0001).
Patient characteristics including age, gender, medical
history, clinical, laboratory and surgical procedures
are identified in Table 1.
Surgery
A large number of patients admitted for DFI required a
surgical procedure (n = 126 out of 156, 81 %) and the
majority of these were undertaken in patients with no
contact (n = 94 out of 126, 74.7 %). Amputation was the
most common surgical intervention (n = 100 out of 126,
72 %) with lower extremity amputation being under-
taken more frequently in patients with no contact (no
contact = 77, 82 % vs. contact = 23, 72 %, p = 0.23). Popu-
lation estimates for our groups suggested that admission
and amputation in the no contact group were over rep-
resented, the expected number of amputations should
have been 55, however the observed number was 77, 22
more than expected (p = 0.0001).
Revascularisations utilising percutaneous transluminal
angioplasty (PTA) were performed in 34 (36 %) of no
contact patients and 6 contact (19 %) patients with a
trend towards significance (p = 0.054). Regardless of con-
tact status, digital amputations were the most commonly
performed amputation (n = 67, 43 %)
Length of stay
On average, the median LOS in the no contact group
was 3 days longer than those with contact (contact =
8 days, IQR 7 to 12 vs. no contact = 11 days, IQR 6 to
24, p = 0.063). LOS was influenced by the requirement
to undergo a surgical procedure. Regardless of contact
status, the LOS for admissions not requiring surgery was
7 days (IQR 5 to 10 days) while LOS increased to 11 days
in those patients undergoing a surgical procedure (IQR
8 to 21 days, p = 0.008).
Infection severity and classification
IDSA moderate infection was the most common presen-
tation regardless of contact status (n = 105 of 156, 67 %).
IDSA severe infection presentations occurred in 34 %
(n = 39 of 116) of the no contact group and 30 % of
the contact group (n = 12 of 40, p = 0.67), however no
contact patients presenting with IDSA severe infection re-
quired greater numbers of lower extremity amputation
with odds of 4.9 times higher than those with contact to a
MDT-HRFS (no contact with severe infection and am-
putation = 34, 82.9 % vs. contact with severe infection
and amputation = 7, 17.1 %, OR 4.9, 95 % CI 1.1 to
21.4, p = 0.037).
Laboratory data
Inflammatory markers were similar between groups,
with no significant difference; white cell count (no con-
tact = 12.1 x 10^9/L, IQR 10 to 15 vs. contact =10.7 x
10^9/L, IQR 8 to 15, p = 0.241, 95%CI-0.87 to 3.45),
erythrocyte sedimentation rate (no contact = 57 mm/
min, IQR 26 to 77 vs. contact = 57 mm/min, IQR 34 to
86, p = 0.69), C-reactive protein (no contact = 76 mg/L,
IQR 32 to 172 vs. contact = 70 mg/L, IQR 23 to 155,
p = 0.99).
Culture results
Two hundred fifteen pathogens of suspected infection
were isolated from soft tissue and bone cultures in 129
patients. Polymicrobial infections were more common
than monomicrobial infections (monomicrobial = 44 pa-
tients, 28.2 % versus polymicrobial = 85 patients, 54.5 %).
Culture results were unavailable for 27 patients (17.3 %)
who all received empiric antimicrobial therapy.
Gram-positive cocci were the predominating pathogens
with the combination of Methicillin-sensitive Staphylococ-
cus aureus (MSSA) andMethicillin-resistant Staphylococcus
aureus (MRSA) accounting for half of all gram-positive cul-
tures (MSSA= 37 of 118, 31 % and MRSA= 31 of 118,
26 %). Gram-negative bacteria represented 47 % of cultures
with gram-negative rods predominating as probable coloni-
sers (71 %, 69 of 97).
Cost analysis
The estimated total cost of foot infection in this cohort
was $4,264,214. The total cost was significantly higher in
the no contact $ 3,169,083 primarily due to the higher
rate of patient presentation and surgical intervention. In
comparison, the contact group costs amounted to 97 %
less in total costs, ($1,095,131) however, the average cost
per patient separation was similar between groups (no
contact = $ 22,475 vs. contact = $21,473, p = 0.763).
Discussion
While evidence exists for reduction of diabetes related
lower extremity amputation through the use of multidis-
ciplinary high risk foot care services [10, 23, 24] the link
between reduction in infections and the use of multidis-
ciplinary foot services is less clear. This retrospective
study suggests access to the MDT-HRFS within the hos-
pital at the time of admission for DFI provides similar
clinical outcomes regardless of contact status prior to
admission. However, in this study patients with DFI who
had no previous contact with a MDT-HRFS constituted
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Table 1 Patient characteristics for contact or no contact with a MDT-HRFS
Contact (n = 40) No Contact (n = 116) Total (n = 156) p-value
Demographics
Mean Age (±SD) 63.4 (±11.8) 65.5 (±14.1) 65 (±13.5) 0.40
Male, n (%) 27 (67.5) 78 (67.2) 105 (67.3)
Female, n (%) 13 (32.5) 38 (32.8) 51 (32.7) 0.98
Medical history
Diabetes Type 1, n (%) 4 (10.0) 8 (6.9) 12 (7.7)
Diabetes Type 2, n (%) 36 (90.0) 108 (93.1) 144 (92.3) 0.54
Duration of Diabetes (±SD) 15.5 (±5.7) 15.8 (±8.5) 15.7 (±7.8) 0.86
HbA1C (mmol/mol)/IFCC 8.4 (±2.2)/68 8.7 (±2.6)/72 8.6 (±2.5)/70.5 0.44
Peripheral Neuropathy, n (%) 35 (87.5) 97 (83.6) 132 (84.6) 0.56
Peripheral Arterial Disease, n (%) 33 (82.5) 95 (81.9) 128 (82.1) 0.93
Ischemic Heart Disease, n (%) 20 (50) 58 (50) 78 (50) 1.00
Hypertension, n (%) 36 (90) 98 (84.5) 134 (85.9) 0.39
CKD stage 5, n (%) 9 (22.5) 19 (16.4) 28 (17.9) 0.21
eGFR (±SD) 41.3 (±26.5) 47.8 (±28.7) 46.2 (±28.2) 0.001*
Length of Stay, n (IQR) 8 (7–12) 11 (6–24) 10 (10–19.5) 0.63
LAB
White Cell Count, n (IQR) 10.75 (8–15) 12.1 (10–15) 11.8 (9–15) 0.24
Presenting ESR (mmol/L), n (IQR) 57 (34–86) 57 (26–77) 57 (27–77) 0.69
Presenting CRP (mg/l), n (IQR) 76.35 (23–155) 69.75 (32–172) 73.7 (29–166) 0.99
Infection severity
IDSA grade Moderate, n (%) 28 (70 %) 77 (66.4 %) 105 (67.3 %) 0.68
IDSA grade Severe, n (%) 12 (30 %) 39 (33.6 %) 51 (32.7 %) 0.68
Texas classification
1B, n (%) 1 (2.5) 6 (5.2) 7 (4.5) 0.48
1D, n (%) 6 (15) 21 (18.1) 27 (17.3) 0.66
2B, n (%) 3 (7.5) 11 (9.5) 14 (9) 0.71
2D, n (%) 12 (30) 52 (44.8) 64 (41) 0.10
3B, n (%) 3 (7.5) 5 (4.3) 8 (5.1) 0.43
3D, n (%) 15 (37.5) 21 (18.1) 36 (23.1) 0.01*
Surgery type
Surgical debridement, n (%) 7 (17.5) 28 (24.1) 35 (22.4) 0.39
PTA, n (%) 6 (15) 34 (29.3) 40 (25.6) 0.08*
Bypass, n (%) 0 (0) 3 (2.6) 3 (1.9) 0.31
Amputation, n (%) 23 (57.5) 77 (66.4) 100 (64.1) 0.32
Forefoot/digital, n (%) 16 (40) 51 (44) 67 (42.9) 0.66
TMA, n (%) 0 (0) 0 (0) 0 (0)
BKA, n (%) 8 (20) 18 (15.5) 26 (16.7) 0.51
AKA, n (%) 0 (0) 8 (6.9) 8 (5.1) 0.09*
ESR erythrocyte sedimentation rate, CRP c-reactive protein, CKD chronic kidney disease, eGFR estimated glomelular filtration rate, PTA percutaneous
transluminal angioplasty
*p-value <0.05
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around three times the number of hospital admissions
for lower extremity amputation compared to those with
prior contact. Whilst this rate of lower extremity ampu-
tation was not significantly different between the two
groups, population estimates suggest that the number of
expected amputations in the no contact group should
have been 55, however the observed number was 77, 22
more than expected.
The large numbers of patients with no contact to MDT-
HRFS within a large district in Sydney, Australia is of con-
cern, particularly with four services in our District, with a
no-wait policy for urgent referrals. Population estimates
suggest this group are over represented in relation to ad-
mission and amputation rates. Screening is the key to
identify people with diabetes who are at risk of ulceration
and complication [25]. This has been emphasised in many
health policy documents [7, 8]. A large component of this
work is often undertaken within the primary care setting.
Whilst the baseline characteristics of the contact and no
contact group were similar, it is surprising given the long
standing duration of diabetes and co-morbidities that re-
ferral to a MDT-HRFS did not routinely occur.
Our results are consistent with the contention that
MDT-HRFS reduce the risk of amputation particularly
in association with severe infection. Severe DFI was as-
sociated with a five-fold increase in the odds of requiring
a lower extremity amputation. Using the same criteria
for grading severity of infection as in this study, Wukich
and colleagues evaluated the outcomes of patients with
moderate and severe DFI. Their retrospective study of
119 patients reported a similar seven-fold increase in the
risk of patients undergoing amputation if they presented
with severe DFI (7.12 RR 95 % CI 1.83-41.05) [26].
The median LOS in patients with no contact was three
days longer than those with contact. While this was not
significant between the groups the additional hospital
days are associated with an increased burden on the
healthcare system and this number is higher than na-
tional averages for admission with cellulitis without
complications [27]. The most likely explanation for this
finding is the higher number of surgical procedures
undertaken during admission in this study population.
This study has limitations that should be noted. The
retrospective design relies heavily on both the ability of
the treating team and the clinical coding team to accur-
ately capture all relevant patient data and assign a cor-
rect primary diagnosis [26]. Errors may also occur in the
ICD-10 conversion to the correct DRG [28]. A prospect-
ive study would allow greater accuracy in coding and
classification.
The AR-DRG clinical coding which is used to estimate
healthcare costs can be influenced by under and over-
coding and by coding errors. In this study, these prob-
lems were avoided by allocating AR-DRG codes for each
submission after manually cross-referencing all of the
data between the ICD-10 search, eMR and patient paper
charts, rather than relying solely on the patient paper
charts.
Conclusion
This single-centre study indicates that patients with no
contact with a multi-disciplinary high risk foot service
account for around 75 % of hospital admissions and am-
putations for DFI. Given the evidence about the effect-
iveness of MDT-HRFS and the need for early
identification and prevention the over representation of
the no contact group is of concern. Appropriate referral
and early access to these specialist clinics is needed. Pri-
mary health carers and general practitioners should be
aware of patients that should be referred to MDT-HRFS.
Future studies should be prospective and a multi-site
study would provide a national perspective. Studies
should also explore the potential barriers to early referral
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